DZ2691A1 - Compositions insolubles pour contrôler le glucose sanguin. - Google Patents

Compositions insolubles pour contrôler le glucose sanguin.

Info

Publication number
DZ2691A1
DZ2691A1 DZ980301A DZ980301A DZ2691A1 DZ 2691 A1 DZ2691 A1 DZ 2691A1 DZ 980301 A DZ980301 A DZ 980301A DZ 980301 A DZ980301 A DZ 980301A DZ 2691 A1 DZ2691 A1 DZ 2691A1
Authority
DZ
Algeria
Prior art keywords
blood glucose
controlling blood
insoluble compositions
insoluble
compositions
Prior art date
Application number
DZ980301A
Other languages
English (en)
Inventor
Mark Alurence Brader
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ2691A1 publication Critical patent/DZ2691A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DZ980301A 1997-12-23 1998-12-22 Compositions insolubles pour contrôler le glucose sanguin. DZ2691A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6860197P 1997-12-23 1997-12-23
US8885998P 1998-06-11 1998-06-11
US10994098P 1998-11-25 1998-11-25

Publications (1)

Publication Number Publication Date
DZ2691A1 true DZ2691A1 (fr) 2003-03-29

Family

ID=27371371

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980301A DZ2691A1 (fr) 1997-12-23 1998-12-22 Compositions insolubles pour contrôler le glucose sanguin.

Country Status (24)

Country Link
US (2) US6531448B1 (fr)
EP (1) EP0925792B1 (fr)
JP (1) JP2001526225A (fr)
KR (1) KR20010024799A (fr)
CN (1) CN1284876A (fr)
AR (1) AR019807A1 (fr)
AT (1) ATE264690T1 (fr)
AU (1) AU2008899A (fr)
BR (1) BR9814471A (fr)
CA (1) CA2315300A1 (fr)
CO (1) CO4970787A1 (fr)
DE (1) DE69823319D1 (fr)
DZ (1) DZ2691A1 (fr)
EA (1) EA003394B1 (fr)
HR (1) HRP20000427A2 (fr)
HU (1) HUP0100243A3 (fr)
ID (1) ID25476A (fr)
IL (1) IL136724A0 (fr)
NO (1) NO20003269L (fr)
NZ (1) NZ505091A (fr)
PE (1) PE20000106A1 (fr)
PL (1) PL341300A1 (fr)
TR (1) TR200001935T2 (fr)
WO (1) WO1999032116A1 (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911035A3 (fr) * 1997-10-24 2002-08-21 Eli Lilly And Company Compositions non solubles d' insuline
US6531448B1 (en) * 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US6734162B2 (en) 2000-01-24 2004-05-11 Minimed Inc. Mixed buffer system for stabilizing polypeptide formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
US7238663B2 (en) 2001-08-28 2007-07-03 Eli Lilly And Company Pre-mixes of GLP-1 and basal insulin
MXPA04003569A (es) 2001-10-19 2004-07-23 Lilly Co Eli Mezclas bifasicas de glp-1 e insulina.
WO2003053460A1 (fr) * 2001-12-19 2003-07-03 Eli Lilly And Company Compositions cristallines pour reguler la glycemie
AU2002359730A1 (en) * 2001-12-21 2003-07-30 Smithkline Beecham Corporation Compositions and methods for altering glucose production
WO2003094956A1 (fr) 2002-05-07 2003-11-20 Novo Nordisk A/S Preparations solubles comprenant de l'insuline monomere et de l'insuline acylee
EP2460530A3 (fr) 2002-12-31 2012-08-29 Althea Technologies, Inc. Cristaux d'hormone de croissance humaine et leurs procédés de préparation
JP2006519791A (ja) * 2003-03-13 2006-08-31 ノボ　ノルディスク　アクティーゼルスカブ 新規なｎｐｈインスリン製剤
CA2518776A1 (fr) * 2003-04-29 2004-11-11 Eli Lilly And Company Analogues de l'insuline ayant une action prolongee
US20050054818A1 (en) * 2003-07-02 2005-03-10 Brader Mark Laurence Crystalline compositions for controlling blood glucose
KR101159559B1 (ko) * 2003-08-05 2012-06-26 노보 노르디스크 에이/에스 신규의 인슐린 유도체
AU2014200247B2 (en) * 2004-07-19 2015-05-14 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
NZ553263A (en) 2004-07-19 2010-06-25 Biocon Ltd Insulin-oligomer conjugates, formulations and uses thereof
PL373543A1 (pl) * 2005-03-10 2006-09-18 Instytut Biotechnologii i Antybiotyków Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
US7790679B2 (en) 2005-08-05 2010-09-07 Amgen Inc. Pharmaceutical formulations
AU2006286052B2 (en) * 2005-08-29 2011-02-03 Ajinomoto Co., Inc. Nutrient composition
EP1969004B1 (fr) * 2005-12-28 2011-08-10 Novo Nordisk A/S Compositions renfermant une insuline acylée et du zinc et procédé de fabrication des dites compositions
WO2007081824A2 (fr) * 2006-01-06 2007-07-19 Case Western Reserve University Protéines résistantes à la fibrillation
US8927015B2 (en) * 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
US9018161B2 (en) 2006-09-22 2015-04-28 Novo Nordisk A/S Protease resistant insulin analogues
EP2074140B8 (fr) * 2006-10-04 2015-10-28 Case Western Reserve University Insuline et analogues de l'insuline résistants à la fibrillation
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5552046B2 (ja) * 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー／エス インスリン誘導体を含有する薬学的製剤
WO2009050738A2 (fr) * 2007-10-16 2009-04-23 Biocon Limited Composition pharmaceutique solide administrable par voie orale et procédé associé
PT2597103T (pt) 2007-11-16 2017-02-08 Novo Nordisk As Composições farmacêuticas contendo insulina e um péptido insulinotrófico
WO2009112583A2 (fr) 2008-03-14 2009-09-17 Novo Nordisk A/S Analogues de l’insuline stabilisés une protéase
PL2254906T3 (pl) 2008-03-18 2017-04-28 Novo Nordisk A/S Stabilizowane względem proteaz, acylowane analogi insuliny
US20110034385A1 (en) * 2008-04-07 2011-02-10 National Institute Of Immunology Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder
WO2009129250A2 (fr) * 2008-04-14 2009-10-22 Case Western Reserve University Analogues de l'insuline à prendre au moment des repas de stabilité améliorée
BRPI0911571A2 (pt) * 2008-04-22 2018-04-03 Univ Case Western Reserve método para tratar um mamífero, análogo de insulina, ácido nucléico e célula hospedeira
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
WO2011072288A2 (fr) 2009-12-11 2011-06-16 Case Western Reserve University Analogues de l'insuline comprenant des acides aminés chlorés
KR20120129875A (ko) * 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
EP2344200A2 (fr) * 2008-09-19 2011-07-20 Nektar Therapeutics Peptides thérapeutiques modifiés, procédés pour les préparer et les utiliser
RU2540922C2 (ru) * 2008-10-30 2015-02-10 Ново Нордиск А/С Лечение сахарного диабета с использованием инъекций инсулина с частотой менее одного раза в день
US8399407B2 (en) * 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
CN102770152B (zh) 2009-11-25 2016-07-06 阿瑞斯根股份有限公司 肽类的粘膜递送
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
CN102219851B (zh) * 2011-05-09 2012-05-30 甘李药业有限公司 甘精胰岛素结晶的制备方法
WO2012171994A1 (fr) * 2011-06-15 2012-12-20 Novo Nordisk A/S Insulines à substitutions multiples
MX2014012096A (es) 2012-04-11 2014-11-21 Novo Nordisk As Formulaciones de insulina.
DE112013002122T5 (de) 2012-04-18 2014-12-31 Waters Technologies Corporation Verfahren zur Quantifizierung von Polypeptiden mittels Massenspektrometrie
AU2013255880B2 (en) * 2012-05-01 2017-07-20 Novo Nordisk A/S Pharmaceutical composition
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
WO2014099577A1 (fr) * 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Procédé pour purifier l'insuline et ses analogues
US9707275B2 (en) * 2012-12-19 2017-07-18 Wockhardt Limited Stable aqueous composition comprising human insulin or an analogue or derivative thereof
WO2014116753A1 (fr) * 2013-01-22 2014-07-31 Case Western Reserve University Analogues d'insuline tronqués à leur extrémité n-terminale
CN103145829B (zh) * 2013-03-29 2015-06-03 江苏诺泰制药有限公司 一种地特胰岛素的纯化方法
EP2991672A1 (fr) 2013-04-30 2016-03-09 Novo Nordisk A/S Schéma d'administration d'un nouveau type
SI3055325T1 (en) 2013-10-07 2018-05-31 Novo Nordisk A/S NEW DERIVATIVE ANALOGUE INSULINE
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
KR102569743B1 (ko) 2014-10-06 2023-08-23 케이스 웨스턴 리저브 유니버시티 이상 단일 사슬 인슐린 유사체
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
WO2016069475A1 (fr) 2014-10-27 2016-05-06 Aseko, Inc. Gestion sous-cutanée de patient externe
AU2016308953B2 (en) 2015-08-20 2020-09-10 Glytec, Llc Diabetes management therapy advisor
TWI700091B (zh) 2016-12-16 2020-08-01 丹麥商諾佛 儂迪克股份有限公司 含胰島素醫藥組成物
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
KR102253318B1 (ko) * 2020-06-02 2021-05-18 (주)위바이오트리 금속 상 변환 화합물 및 이의 제조 방법
CN114306577B (zh) * 2020-10-10 2024-04-09 南京汉欣医药科技有限公司 一种门冬胰岛素30混悬液的制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2801953A (en) 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US2849370A (en) 1953-06-04 1958-08-26 Novo Terapeutisk Labortorium A Injectable insulin preparations with protracted effect and process of producing same
US3102077A (en) 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US3060093A (en) 1957-07-18 1962-10-23 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form and method of preparation
US3012077A (en) * 1960-03-11 1961-12-05 Union Carbide Corp Process for the production of organo sulfur compounds
DE1793517C3 (de) 1968-09-28 1974-12-05 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung
US3950517A (en) 1970-05-08 1976-04-13 National Research Development Corporation Insulin derivatives
US3869437A (en) 1970-05-08 1975-03-04 Nat Res Dev Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
GB1381274A (en) 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
US3868358A (en) 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
US3864325A (en) 1971-11-18 1975-02-04 Nat Res Dev (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
US3907763A (en) 1972-03-01 1975-09-23 Bayer Ag Insulin derivatives crosslinked by a dicarboxylic acid moiety
US4183849A (en) 1975-01-15 1980-01-15 Nordisk Insulinlaboratorium Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
JPS55138393A (en) 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
JPS55138391A (en) 1979-04-13 1980-10-29 Shionogi & Co Ltd New synthetic method of peptide derivative
IE50892B1 (en) 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
DE3101382A1 (de) 1981-01-17 1982-09-02 Hoechst Ag, 6000 Frankfurt "verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten"
WO1983001074A1 (fr) 1981-09-15 1983-03-31 Andresen, Finn, Hede Procede de preparation d'insuline humaine ou de ses esters b-30
DK353781A (da) 1981-08-10 1983-02-11 Novo Industri As Fremgangsmaade til fremstilling af insulinderivater
DE3326473A1 (de) 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3717370A1 (de) 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
JPH01254699A (ja) 1988-04-05 1989-10-11 Kodama Kk インスリン誘導体及びその用途
US5149777A (en) 1988-07-20 1992-09-22 Novo Nordisk A/S Human insulin analogs and preparations containing them
AU641631B2 (en) 1988-12-23 1993-09-30 Novo Nordisk A/S Human insulin analogues
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US5514646A (en) 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
DK134189D0 (da) 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AT400337B (de) * 1990-05-02 1995-12-27 Plasser Bahnbaumasch Franz Gleisstopfmaschine mit in gleisquerrichtung verstellbaren stopfeinheiten
DK72793D0 (da) 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
JP2837956B2 (ja) 1993-06-21 1998-12-16 ノボ ノルディスク アクティーゼルスカブ Ａｓｐ▲上Ｂ２８▼インスリン結晶
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
RO112873B1 (ro) 1993-09-17 1998-01-30 Novo Nordisk As Derivati de insulina
US5461031A (en) 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5597893A (en) 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
HUP9800523A3 (en) 1995-03-17 1998-09-28 Novo Nordisk As Insulin derivatives
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US5877153A (en) 1996-06-11 1999-03-02 Commonwealth Biotechnologies Inc. Heparin-binding peptides
CA2258099A1 (fr) 1996-06-20 1997-12-24 Novo Nordisk A/S Preparations a base d'insuline contenant des glucides
US5948751A (en) 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
WO1998034953A1 (fr) 1997-02-07 1998-08-13 Novo Nordisk A/S Cristallisation de proteines
US5898028A (en) 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
BR9813111A (pt) 1997-10-24 2000-08-15 Lilly Co Eli Composições de insulina insolúveis
ZA989744B (en) 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
US6531448B1 (en) * 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose

Also Published As

Publication number Publication date
AR019807A1 (es) 2002-03-20
US20030144181A1 (en) 2003-07-31
US6531448B1 (en) 2003-03-11
EP0925792A2 (fr) 1999-06-30
EA200000708A1 (ru) 2000-12-25
CN1284876A (zh) 2001-02-21
PE20000106A1 (es) 2000-02-09
CO4970787A1 (es) 2000-11-07
HUP0100243A2 (hu) 2001-08-28
JP2001526225A (ja) 2001-12-18
DE69823319D1 (de) 2004-05-27
EP0925792A3 (fr) 2001-09-12
NO20003269L (no) 2000-08-23
KR20010024799A (ko) 2001-03-26
WO1999032116A1 (fr) 1999-07-01
ID25476A (id) 2000-10-05
EA003394B1 (ru) 2003-04-24
PL341300A1 (en) 2001-04-09
NO20003269D0 (no) 2000-06-22
BR9814471A (pt) 2000-10-10
AU2008899A (en) 1999-07-12
IL136724A0 (en) 2001-06-14
EP0925792B1 (fr) 2004-04-21
CA2315300A1 (fr) 1999-07-01
NZ505091A (en) 2002-11-26
ATE264690T1 (de) 2004-05-15
TR200001935T2 (tr) 2000-12-21
HRP20000427A2 (en) 2001-06-30
HUP0100243A3 (en) 2001-09-28

Similar Documents

Publication Publication Date Title
DZ2691A1 (fr) Compositions insolubles pour contrôler le glucose sanguin.
ZA200200156B (en) Peptides that lower blood glucose levels.
ZA200108218B (en) Vascular surgery.
NO20002038D0 (no) Uløselig insulinsammensetning
BR9909681B1 (pt) estrutura de seringa.
DE50013200D1 (de) Intravasale blutpumpe
BR9816191B1 (pt) unidade de ampola/portador.
MA26780A1 (fr) Activateurs de la glucokinase.
AU2937600A (en) Blood glucose level control
BR0014930B1 (pt) cÂnula.
DZ3001A1 (fr) Sel de potassium d'oméprazole-(S).
BR0012357B1 (pt) elevador de colheitas.
IT1305301B1 (it) Raccordo per anastomosi vascolari.
FR2763498B1 (fr) Endoscope, en particulier mediastinoscope
BR0004161B1 (pt) solução de molho ácido.
ZA989644B (en) Insoluble insulen compositions.
ZA9811728B (en) Insoluble compositions for controlling blood glucose.
ZA969927B (en) 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives.
ES1039434Y (es) Estanteria.
ES1041880Y (es) Puya de picador.
FR2781516B1 (fr) Charniere pour elements articules, notamment des elements articules de mobilier
ITVC980018A0 (it) Biscotti "le risaiole".
ES1042496Y (es) "pilona sumible".
ZA9811387B (en) Improving ocular blood flow with brinzolamide.
ES1036080Y (es) Zapatilla fisiologica.